Cargando…

Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics

Application of acute therapies such as thrombolysis for ischaemic stroke (IS) is constrained because of diagnostic uncertainty and the dynamic nature of stroke biology. To investigate changes in blood proteins after stroke and as a result of thrombolysis treatment we performed label-free quantitativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagonnier, Marie, Cooke, Ira Robin, Faou, Pierre, Sidon, Tara Kate, Dewey, Helen Margaret, Donnan, Geoffrey Alan, Howells, David William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751906/ https://www.ncbi.nlm.nih.gov/pubmed/29308009 http://dx.doi.org/10.1177/1177271917749216

Ejemplares similares

Acute Stroke Biomarkers: Are We There Yet?
por: Dagonnier, Marie, et al.
Publicado: (2021)

Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis
por: Nguyen, Vinh A., et al.
Publicado: (2020)

A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression – A Pilot Study
por: Nguyen, Vinh A., et al.
Publicado: (2016)

Hyperacute changes in blood mRNA expression profiles of rats after middle cerebral artery occlusion: Towards a stroke time signature
por: Dagonnier, Marie, et al.
Publicado: (2018)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

Proteomic Analysis and Discovery Using Affinity Proteomics and Mass Spectrometry
por: Olsson, Niclas, et al.
Publicado: (2011)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Discovery of Candidate Stool Biomarker Proteins for Biliary Atresia Using Proteome Analysis by Data-Independent Acquisition Mass Spectrometry
por: Watanabe, Eiichiro, et al.
Publicado: (2020)

Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021)

Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics
por: Brusniak, Mi-Youn, et al.
Publicado: (2008)

Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
por: Fischer, Roman, et al.
Publicado: (2012)

The discovery and identification of a candidate proteomic biomarker of active tuberculosis
por: Liu, Jiyan, et al.
Publicado: (2013)

Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders
por: Venugopal, Abhilash, et al.
Publicado: (2009)

Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry
por: Mun, Sora, et al.
Publicado: (2019)

FAST-IT: Find A Simple Test — In TIA (transient ischaemic attack): a prospective cohort study to develop a multivariable prediction model for diagnosis of TIA through proteomic discovery and candidate lipid mass spectrometry, neuroimaging and machine learning—study protocol
por: Milton, Austin G, et al.
Publicado: (2022)

A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis
por: Nallagangula, Krishna Sumanth, et al.
Publicado: (2018)

Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers
por: Buttacavoli, Miriam, et al.
Publicado: (2020)

Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
por: Wu, Jianqiang, et al.
Publicado: (2020)

Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Jang, Han Na, et al.
Publicado: (2021)

Mass spectrometry-based metabolomics for the discovery of candidate markers of flavonoid and polyphenolic intake in adults
por: Charles, David, et al.
Publicado: (2021)

Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials
por: Rewell, Sarah S. J., et al.
Publicado: (2017)

Family physician decisions following stroke symptom onset and delay times to ambulance call
por: Mosley, Ian, et al.
Publicado: (2011)

Mobilization after thrombolysis (rtPA) within 24 hours of acute stroke: what factors influence inclusion of patients in A Very Early Rehabilitation Trial (AVERT)?
por: Muhl, Linnéa, et al.
Publicado: (2014)

Hypothermia protects human neurons
por: Antonic, Ana, et al.
Publicado: (2014)

Automated Sample Preparation Platform for Mass Spectrometry-Based Plasma Proteomics and Biomarker Discovery
por: Guryča, Vilém, et al.
Publicado: (2014)

Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application
por: Huang, Rongrong, et al.
Publicado: (2017)

TIPS-07 LONGITUDINAL CSF PROTEOMICS FOR MONITORING AND PHARMACODYNAMIC BIOMARKER DISCOVERY
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2023)

The proteomics analysis of the effects of Zhishi Rhubarb soup on ischaemic stroke
por: Zhang, Jing-Hua, et al.
Publicado: (2021)

Discovery of Prognostic Biomarker Candidates of Lacunar Infarction by Quantitative Proteomics of Microvesicles Enriched Plasma
por: Datta, Arnab, et al.
Publicado: (2014)

The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches
por: Muneer, Ather
Publicado: (2020)

Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
por: Paul, Debasish, et al.
Publicado: (2013)

Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
por: Ma, Jessica Yuen Wuen, et al.
Publicado: (2021)

Where Will the Next Generation of Stroke Treatments Come From?
por: Howells, D. W., et al.
Publicado: (2010)

Automated biomarker candidate discovery in imaging mass spectrometry data through spatially localized Shapley additive explanations
por: Tideman, Leonoor E.M., et al.
Publicado: (2021)

Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery
por: Orton, Dennis J., et al.
Publicado: (2013)

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
por: van der Wijngaart, Hanneke, et al.
Publicado: (2023)

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016)

Top-Down Proteomics with Mass Spectrometry Imaging: A Pilot Study towards Discovery of Biomarkers for Neurodevelopmental Disorders
por: Ye, Hui, et al.
Publicado: (2014)

Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of Tuberculosis Diagnostic Biomarker Signature
por: Fernandes, Ana Filipa, et al.
Publicado: (2022)

Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics
por: Oh, Sungtaek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nktub0tkrus2erd18f81vf3cm2